No difference in mortality in undetected coeliac disease compared with the general population: A UK cohort study

Alimentary Pharmacology and Therapeutics

Volumn 34, Issue 8, 2011, Pages 1012-1019

  Canavan, C ^a   Logan, R F ^a,b   Khaw, K T ^c   West, J ^a,b  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOMYSIUM ANTIBODY;

ADULT; AGED; ANTIBODY DETECTION; ARTICLE; CAUSE OF DEATH; CELIAC DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC ERROR; FEMALE; HUMAN; ISCHEMIA; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MORTALITY; POPULATION RESEARCH; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RISK ASSESSMENT; UNITED KINGDOM;

AGED; CAUSE OF DEATH; CELIAC DISEASE; COHORT STUDIES; CONFIDENCE INTERVALS; FEMALE; GREAT BRITAIN; HUMANS; MALE; MIDDLE AGED; RISK FACTORS;

EID: 80053215542     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2011.04811.x     Document Type: Article

References (17)

1. Mustalahti K, Catassi C, Reunanen A, et al. The prevalence of celiac disease in Europe: results of a centralized, international mass screening project. Ann Med 2010; 42: 587-95.
2. Korponay-Szabo IR, Szabados K, Pusztai J, et al. Population screening for coeliac disease in primary care by district nurses using a rapid antibody test: diagnostic accuracy and feasibility study. BMJ 2007; 335: 1244-7.
3. Baldas V, Tommasini A, Trevisiol C, et al. Development of a novel rapid non-invasive screening test for coeliac disease. Gut 2000; 47: 628-31.
4. Raivio T, Kaukinen K, Nemes E, et al. Self transglutaminase-based rapid coeliac disease antibody detection by a lateral flow method. Aliment Pharmacol Ther 2006; 24: 147-54. (Pubitemid 43894015)
5. Viljamaa M, Kaukinen K, Pukkala E, et al. Malignancies and mortality in patients with coeliac disease and dermatitis herpetiformis: 30-year population-based study. Dig Liver Dis 2006; 38: 374-80. (Pubitemid 44356222)
6. Biagi F, Corazza GR,. Mortality in celiac disease. Nat Rev Gastroenterol Hepatol 2010; 7: 158-62.
7. Lohi S, Maki M, Rissanen H, et al. Prognosis of unrecognized coeliac disease as regards mortality: a population-based cohort study. Ann Med 2009; 23: 1-8.
8. Godfrey JD, Brantner TL, Brinjikji W, et al. Morbidity and mortality among older individuals with undiagnosed celiac disease. Gastroenterology 2010; 139: 763-9.
9. Rubio-Tapia A, Kyle RA, Kaplan EL, et al. Increased prevalence and mortality in undiagnosed celiac disease. Gastroenterology 2009; 137: 88-93.
10. Metzger MH, Heier M, Maki M, et al. Mortality excess in individuals with elevated IgA anti-transglutaminase antibodies: the KORA/MONICA Augsburg Cohort Study 1989-1998. Eur J Epidemiol 2006; 21: 359-65. (Pubitemid 44050805)
11. Johnston SD, Watson RG, McMillan SA, et al. Coeliac disease detected by screening is not silent-simply unrecognized. QJM 1998; 91: 853-60. (Pubitemid 29027072)
12. Trivedi DP, Khaw KT,. Bone mineral density at the hip predicts mortality in elderly men. Osteoporos Int 2001; 12: 259-65. (Pubitemid 34912731)
13. West J, Logan RF, Hill PG, et al. Seroprevalence, correlates, and characteristics of undetected coeliac disease in England. Gut 2003; 52: 960-5. (Pubitemid 36765286)
14. Lewis NR, Scott BB,. Systematic review: the use of serology to exclude or diagnose coeliac disease (a comparison of the endomysial and tissue transglutaminase antibody tests). Aliment Pharmacol Ther 2006; 24: 47-54. (Pubitemid 43894004)
15. Corrao G, Corazza GR, Bagnardi V, et al. Mortality in patients with coeliac disease and their relatives: a cohort study. Lancet 2001; 358: 356-61. (Pubitemid 32739095)
16. Ludvigsson JF, Montgomery SM, Ekbom A, et al. Small-intestinal histopathology and mortality risk in celiac disease. JAM 2009; 302: 1171-8.
17. Rampertab SD, Forde KA, Green PH,. Small bowel neoplasia in coeliac disease. Gut 2003; 52: 1211-4. (Pubitemid 36877438)